Cleared Traditional

K171007 - Fluorescence Mode

K171007 is the FDA 510(k) clearance for Fluorescence Mode by Carl Zeiss Suzhou Co., Ltd.. It is a Class 2 Dental device (product code NBL) cleared through the Traditional 510(k) pathway after a 394-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2018
Decision
394d
Days
Class 2
Risk

K171007 is an FDA 510(k) clearance for the Fluorescence Mode. Classified as Laser, Fluorescence Caries Detection (product code NBL), Class II - Special Controls.

Submitted by Carl Zeiss Suzhou Co., Ltd. (Suzhou, CN). The FDA issued a Cleared decision on May 3, 2018 after a review of 394 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.1745 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Carl Zeiss Suzhou Co., Ltd. devices

Submission Details

510(k) Number K171007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2017
Decision Date May 03, 2018
Days to Decision 394 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
267d slower than avg
Panel avg: 127d · This submission: 394d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NBL Laser, Fluorescence Caries Detection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.1745
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Consultant

Carl Zeiss Meditec, Inc.
Mandy Ambrecht

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.